Trial Profile
A Double-Blind, Placebo-Controlled Trial of Albendazole in HIV-Positive Patients With Intestinal Microsporidiosis
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 03 Jul 2023
Price :
$35
*
At a glance
- Drugs Albendazole (Primary)
- Indications Microsporidiosis
- Focus Therapeutic Use
- Sponsors GlaxoSmithKline; GSK
- 17 Sep 2014 New trial record